The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Tolucombi 40 mg/12.5 mg tablets

40 mg/12.5 milligram(s) Tablet

Krka d.d., Novo mestoEU/1/13/821/001-010

Main Information

Trade NameTolucombi 40 mg/12.5 mg tablets
Active SubstancesTelmisartan
Hydrochlorothiazide
Strength40 mg/12.5 milligram(s)
Dosage FormTablet
Licence HolderKrka d.d., Novo mesto
Licence NumberEU/1/13/821/001-010

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA07 telmisartan and diuretics

Status

Authorised/WithdrawnAuthorised
Licence Issued13/03/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0050-099-039
Interchangeable List DocumentPDF of Interchangeable List
« Back